PMID- 35120597 OWN - NLM STAT- MEDLINE DCOM- 20220304 LR - 20220304 IS - 1878-3686 (Electronic) IS - 1535-6108 (Linking) VI - 40 IP - 2 DP - 2022 Feb 14 TI - Inflammatory fibroblasts make rectal cancer resistant to radiation therapy. PG - 122-124 LID - S1535-6108(22)00007-1 [pii] LID - 10.1016/j.ccell.2022.01.005 [doi] AB - Colorectal cancer (CRC) is one of the most prevalent cancers worldwide. Still, the molecular mechanisms that drive CRC therapy resistance are incompletely understood. In this issue of Cancer Cell, Nicolas et al. combine several approaches to unravel a critical role for inflammatory cancer-associated fibroblasts (iCAFs) and interleukin 1alpha (IL1alpha) signaling in radiotherapy resistance. CI - Copyright (c) 2022 Elsevier Inc. All rights reserved. FAU - Mhaidly, Rana AU - Mhaidly R AD - Institut Curie, Stress and Cancer Laboratory, Equipe labelisee par la Ligue Nationale contre le Cancer, PSL Research University, 26, Rue d'Ulm, 75248 Paris, France; Inserm, U830, 26, Rue d'Ulm, 75005 Paris, France. FAU - Mechta-Grigoriou, Fatima AU - Mechta-Grigoriou F AD - Institut Curie, Stress and Cancer Laboratory, Equipe labelisee par la Ligue Nationale contre le Cancer, PSL Research University, 26, Rue d'Ulm, 75248 Paris, France; Inserm, U830, 26, Rue d'Ulm, 75005 Paris, France. Electronic address: fatima.mechta-grigoriou@curie.fr. LA - eng PT - Comment PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20220203 PL - United States TA - Cancer Cell JT - Cancer cell JID - 101130617 SB - IM CON - Cancer Cell. 2022 Feb 14;40(2):168-184.e13. PMID: 35120600 MH - *Cancer-Associated Fibroblasts MH - Fibroblasts MH - Humans MH - *Rectal Neoplasms/radiotherapy COIS- Declaration of interests F.M-G. received research support from Innate-Pharma, Roche and Bristol-Myers-Squibb (BMS). R.M. declares no potential conflict of interest. EDAT- 2022/02/06 06:00 MHDA- 2022/03/05 06:00 CRDT- 2022/02/05 05:33 PHST- 2022/02/06 06:00 [pubmed] PHST- 2022/03/05 06:00 [medline] PHST- 2022/02/05 05:33 [entrez] AID - S1535-6108(22)00007-1 [pii] AID - 10.1016/j.ccell.2022.01.005 [doi] PST - ppublish SO - Cancer Cell. 2022 Feb 14;40(2):122-124. doi: 10.1016/j.ccell.2022.01.005. Epub 2022 Feb 3.